Can-Fite BioPharma (CANF) Institutional Ownership $1.58 +0.03 (+1.94%) Closing price 04:00 PM EasternExtended Trading$1.59 +0.01 (+0.63%) As of 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Can-Fite BioPharma (NYSE:CANF)CurrentInstitutional OwnershipPercentage21.00%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$690.62KNumber ofInstitutional Sellers(last 12 months)0 Get CANF Insider Trade Alerts Want to know when executives and insiders are buying or selling Can-Fite BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CANF Institutional Buying and Selling by Quarter Can-Fite BioPharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024Armistice Capital LLC518,853$1.34M0.0%+35.5%14.657% 2/13/2024Armistice Capital LLC154,363$340K0.0%N/A4.361% 1/17/2024Schechter Investment Advisors LLC20,077$44K0.0%N/A0.567% 2/10/2022Acadian Asset Management LLC28,601$36K0.0%-75.1%0.105% 11/16/2021Cetera Advisor Networks LLC130,776$217K0.0%-16.9%0.607% 10/15/2021Fifth Third Bancorp30,000$50K0.0%N/A0.149% 8/6/2021StoneX Group Inc.40,000$91K0.0%N/A0.233% 5/21/2021Citadel Advisors LLC60,077$148K0.0%N/A0.349% 5/19/2021Virtu Financial LLC46,294$114K0.0%-37.5%0.269% 5/18/2021Citadel Advisors LLC60,077$148K0.0%N/A0.349% 5/18/2021Jane Street Group LLC10,665$26K0.0%N/A0.062% 5/14/2021XTX Topco Ltd11,205$28K0.0%N/A0.065% 5/14/2021Stifel Financial Corp12,000$30K0.0%N/A0.070% 3/26/2021Susquehanna International Group LLP15,323$27K0.0%N/A0.090% 2/24/2021Virtu Financial LLC74,052$132K0.0%+445.7%0.479% 2/10/2021Renaissance Technologies LLC118,894$212K0.0%+812.7%0.769% (Data available from 1/1/2016 forward) CANF Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CANF shares? During the previous two years, the following institutional investors and hedge funds held shares of Can-Fite BioPharma shares: Armistice Capital LLC ($1.34M), Schechter Investment Advisors LLC ($44K).Learn more on CANF's institutional investors. What percentage of Can-Fite BioPharma stock is owned by institutional investors? 21.00% of Can-Fite BioPharma stock is owned by institutional investors. Learn more on CANF's institutional investor holdings. Which institutional investors have been buying Can-Fite BioPharma stock? The following institutional investors have purchased Can-Fite BioPharma stock in the last 24 months: Armistice Capital LLC ($290.42K), and Schechter Investment Advisors LLC ($20.08K). How much institutional buying is happening at Can-Fite BioPharma? Institutional investors have bought a total of 310,495 shares in the last 24 months. This purchase volume represents approximately $734.79K in transactions. Related Companies NextCure Major Shareholders Exicure Major Shareholders Cara Therapeutics Major Shareholders Tenax Therapeutics Major Shareholders Athira Pharma Major Shareholders GeoVax Labs Major Shareholders MIRA Pharmaceuticals Major Shareholders Aprea Therapeutics Major Shareholders Cyclo Therapeutics Major Shareholders Bullfrog AI Major Shareholders This page (NYSE:CANF) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can-Fite BioPharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can-Fite BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
